Decreased plasma APOA1 levels are associated with increased severity of placenta accreta spectrum disorders: a nested case-control study
A reduction in maternal plasma APOA1 levels was associated with the severity of PAS. APOA1 may serve as a biomarker for invasive PAS, blood transfusion and hysterectomy in late gestation.
Authors
- Hai Jiang (ORCID: https://orcid.org/0000-0003-0264-7070)
- Huifeng Shi (ORCID: https://orcid.org/0000-0001-6150-8762)
- Yangyu Zhao (ORCID: https://orcid.org/0000-0002-2558-7122)
- Jie Yan (ORCID: https://orcid.org/0000-0001-6877-5193)
- Shuai Zeng (ORCID: https://orcid.org/0000-0003-1242-4938)
- Lian Chen (ORCID: https://orcid.org/0000-0001-9895-3368)
- Jiangxue Qu
Institutions
- Peking University (CN)
- Peking University Third Hospital (CN)
Publication Details
- Journal
- Frontiers in Endocrinology
- Published
- 2025-07-24
- DOI
- https://doi.org/10.3389/fendo.2025.1627377
- Primary Topic
- Maternal and fetal healthcare
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Key Research and Development Program of China